mazindol has been researched along with Diabetes Mellitus in 9 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate, in compliant patients, the pharmaceutical costs of treating obesity with fenfluramine/mazindol, fenfluramine/phentermine, caffeine/ephedrine, or mazindol relative to the pharmaceutical costs of treating obesity-related comorbid conditions and reducing cardiovascular risk." | 3.70 | Pharmaceutical cost savings of treating obesity with weight loss medications. ( Bray, GA; Greenway, FL; Rood, JC; Ryan, DH; Smith, SR; Tucker, EW, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inui, A | 1 |
| Uemoto, M | 1 |
| Takamiya, S | 1 |
| Shibuya, Y | 1 |
| Baba, S | 1 |
| Kasuga, M | 1 |
| Greenway, FL | 1 |
| Ryan, DH | 1 |
| Bray, GA | 1 |
| Rood, JC | 1 |
| Tucker, EW | 1 |
| Smith, SR | 1 |
| Slama, G | 1 |
| Selmi, A | 1 |
| Hautecouverture, M | 1 |
| Tchobroutsky, G | 1 |
| Vasiukova, EA | 1 |
| Granovskaia-Tsvetkova, AM | 1 |
| Dolecek, R | 1 |
| Reil, P | 1 |
| Skarpová, O | 1 |
| Závada, M | 1 |
| Bandisode, MS | 1 |
| Boshell, BR | 1 |
| Felt, V | 1 |
| Nedvídková, J | 1 |
| Sanders, M | 1 |
| Breidahl, H | 1 |
| Jackson, WP | 1 |
| Vinik, AI | 1 |
4 trials available for mazindol and Diabetes Mellitus
| Article | Year |
|---|---|
Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
Topics: Blood Glucose; Body Weight; Cholesterol; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind M | 1978 |
[Mazindol in the treatment of obese diabetic patients].
Topics: Adult; Clinical Trials as Topic; Diabetes Mellitus; Drug Evaluation; Female; Humans; Indoles; Male; | 1976 |
Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
Topics: Body Weight; Clinical Trials as Topic; Diabetes Mellitus; Diazepam; Drug Evaluation; Female; Glucose | 1975 |
Letter: Drugs in obesity.
Topics: Clinical Trials as Topic; Diabetes Mellitus; Humans; Indoles; Mazindol; Obesity; Placebos | 1975 |
5 other studies available for mazindol and Diabetes Mellitus
| Article | Year |
|---|---|
A case of Prader-Willi syndrome with long-term mazindol treatment.
Topics: Adult; Appetite Depressants; Diabetes Mellitus; Drug Therapy, Combination; Humans; Insulin; Male; Ma | 1997 |
Pharmaceutical cost savings of treating obesity with weight loss medications.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Drug | 1999 |
[Obesity and diabetes mellitus].
Topics: Biguanides; Diabetes Mellitus; Diuretics; Female; Humans; Male; Mazindol; Obesity | 1979 |
[Mazindol in the treatment of obesity in diabetics (author's transl)].
Topics: Adolescent; Adult; Body Weight; Diabetes Mellitus; Female; Humans; Indoles; Male; Mazindol; Middle A | 1977 |
The effect of an anorectic agent (Mazindol) on control of obese diabetics.
Topics: Adult; Aged; Diabetes Mellitus; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Indoles; Ins | 1976 |